Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Molecular Diagnostics Adapts to Evolving Diseases (feat. Dr. Tomasz George, CSO)

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances (feat. James Foster, CEO)

Virax Biolabs Introduces Human Papillomavirus (“HPV”) Test Kit

Determining Long Term Immunity May Aid in Understanding Vaccine Efficacy – Interview with Dr. Tomasz George, CSO

by John Parkinson

Virax Biolabs Preparing T-Cell Testing Platform to Provide Consumers With Immune Status Info

by Kelsy Ketchum

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Assessing Adaptive Immune Responses to Viruses to Inform Decisions about Vaccinations with Dr. Tomasz George

By Karen Jagoda